Trial intelligence / Profile preview

[11C]K-2 PET pharmacokinetics in healthy volunteers

jRCT1031230235Recruiting

Sponsor
Takeda Science Foundation
Start
Jul 2023
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of [11C]K-2, sponsored by Takeda Science Foundation. Primary endpoint: Rate constants of [11C]K-2. Started Jul 2023; status: recruiting.

02

Drugs

[11C]K-2

Beyond the preview

Go deeper on jRCT1031230235.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1031230235.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call